Skip to main content

Table 1 Demographic, clinical and pathologic features of patients and general characteristics of healthy controls

From: Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study

Clinical features of patients

N or Mean (SD or %)

Age

68.5 (11.4)

Gender

 Male

51 (89.4)

 Female

6 (10.6)

Disease history

 Primary

31 (54.4)

 Recurrent

26 (45.6)

 Smokers

37 (64.9)

 Diabetes

10 (17.5)

 Hypertension

34 (59.7)

Stage

 Ta

35 (61.4)

 T1

22 (38.6)

Multifocality

 Not

16 (28.1)

 Yes

41 (71.9)

Tumor size > 3 cm

27 (47.4)

Carcinoma in situ

4 (7%)

EORTC score for progression

 Mean value

9.8 (4.9)

 Risk class 1 (2–6)

15 (26.4)

 Risk class 2 (7–13)

29 (50.8)

 Risk class 3 (14–23)

13 (22.8)

Characteristics of healthy controls

Urine Samples

Tissue Samples

 

N or Mean (SD or %)

Total Number

20

10

Age (years)

62.2 (10.1)

69.8 (11)

Gender

 Male

17 (85)

7 (70)

 Female

3 (15)

3 (30)

  1. EORTC European Organization for Research and Treatment of Cancer